[go: up one dir, main page]

About: Metapristone

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Metapristone (developmental code name RU-42633; also known as desmethylmifepristone) is the major metabolite of mifepristone (RU-486, RU-38486) and a selective progesterone receptor modulator (SPRM) which itself was never marketed. It is formed from mifepristone in the liver by the enzyme CYP3A4 via monodemethylation, and circulates at concentrations higher than those of mifepristone. The metabolite retains partial but considerable affinity for the progesterone receptor (PR) and the glucocorticoid receptor (GR) (RBA = 21% and 61% of that of mifepristone for the human forms of these receptors, respectively). On the basis of actions that are apparently independent of its hormonal activity, metapristone is being researched as a potential cancer metastatic chemopreventive agent.

Property Value
dbo:abstract
  • Metapristone (developmental code name RU-42633; also known as desmethylmifepristone) is the major metabolite of mifepristone (RU-486, RU-38486) and a selective progesterone receptor modulator (SPRM) which itself was never marketed. It is formed from mifepristone in the liver by the enzyme CYP3A4 via monodemethylation, and circulates at concentrations higher than those of mifepristone. The metabolite retains partial but considerable affinity for the progesterone receptor (PR) and the glucocorticoid receptor (GR) (RBA = 21% and 61% of that of mifepristone for the human forms of these receptors, respectively). On the basis of actions that are apparently independent of its hormonal activity, metapristone is being researched as a potential cancer metastatic chemopreventive agent. (en)
dbo:casNumber
  • 104004-96-8
dbo:chEMBL
  • 1608
dbo:fdaUniiCode
  • K1P8OGJ86J
dbo:pubchem
  • 10070462
dbo:thumbnail
dbo:wikiPageID
  • 57740433 (xsd:integer)
dbo:wikiPageLength
  • 5523 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1065441412 (xsd:integer)
dbo:wikiPageWikiLink
dbp:c
  • 28 (xsd:integer)
dbp:casNumber
  • 104004 (xsd:integer)
dbp:chembl
  • 1608 (xsd:integer)
dbp:chemspiderid
  • 8246002 (xsd:integer)
dbp:h
  • 33 (xsd:integer)
dbp:iupacName
  • -17 (xsd:integer)
dbp:n
  • 1 (xsd:integer)
dbp:o
  • 2 (xsd:integer)
dbp:pubchem
  • 10070462 (xsd:integer)
dbp:smiles
  • CC#C[C@@]1O (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • IBLXOBHABOVXDY-WKWWZUSTSA-N (en)
dbp:synonyms
  • RU-42633; Desmethylmifepristone; 17β-Hydroxy-11β-[4-phenyl]-17α-estra-4,9-dien-3-one (en)
dbp:unii
  • K1P8OGJ86J (en)
dbp:width
  • 225 (xsd:integer)
dbp:wikiPageUsesTemplate
dct:subject
rdf:type
rdfs:comment
  • Metapristone (developmental code name RU-42633; also known as desmethylmifepristone) is the major metabolite of mifepristone (RU-486, RU-38486) and a selective progesterone receptor modulator (SPRM) which itself was never marketed. It is formed from mifepristone in the liver by the enzyme CYP3A4 via monodemethylation, and circulates at concentrations higher than those of mifepristone. The metabolite retains partial but considerable affinity for the progesterone receptor (PR) and the glucocorticoid receptor (GR) (RBA = 21% and 61% of that of mifepristone for the human forms of these receptors, respectively). On the basis of actions that are apparently independent of its hormonal activity, metapristone is being researched as a potential cancer metastatic chemopreventive agent. (en)
rdfs:label
  • Metapristone (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License